Cargando…
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844197/ https://www.ncbi.nlm.nih.gov/pubmed/31806969 http://dx.doi.org/10.2147/IJN.S234860 |
Ejemplares similares
-
Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
por: Xue, Huiying, et al.
Publicado: (2017) -
Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021) -
Corrigendum to “miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1”
por: Jia-yuan, Xu, et al.
Publicado: (2020) -
Development of an Oral Push–Pull Osmotic Pump of Fenofibrate-Loaded Mesoporous Silica Nanoparticles [Corrigendum]
Publicado: (2022) -
Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
Publicado: (2019)